Target intelligence / Profile preview

ALG1 like 12, pseudogene (ALG1L12P)

Target
ALG1L12P
Molecular classification
Other, Pseudogene
01

Overview

ALG1 like 12, pseudogene (ALG1L12P) is classified as a **pseudogene**, meaning it is a genomic sequence similar to a known gene (in this case, related to the ALG1 gene family) but is non-functional and does not produce a protein product[1][5]. Pseudogenes such as ALG1L12P usually lack protein-coding capability due to mutations or truncations, and are not considered therapeutic targets like receptors, enzymes, or transporters[1][5]. While some pseudogenes may have regulatory roles (for example, acting as noncoding RNAs involved in gene expression regulation or disease modulation), there is currently no evidence that ALG1L12P itself has defined biological functions, disease associations, or drug interactions[1][2][5]. There are no drugs, biomarkers, or established safety concerns specifically related to ALG1L12P. As such, it is not a valid therapeutic target, and the entry should be flagged as non-functional/pseudogene rather than a conventional drug target[1][5].

Other names
ALG1L12P
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on ALG1 like 12, pseudogene (ALG1L12P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ALG1 like 12, pseudogene (ALG1L12P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call